Stockscreener 앱 받기
6.64
1.63%
-0.11
시간 외 거래:
7.15
0.51
+7.68%
전일 마감가:
$6.75
열려 있는:
$6.71
하루 거래량:
22,603
Relative Volume:
0.97
시가총액:
$35.05M
수익:
-
순이익/손실:
$-59.63M
주가수익비율:
-0.6587
EPS:
-10.08
순현금흐름:
$-49.92M
1주 성능:
+3.59%
1개월 성능:
-40.82%
6개월 성능:
-43.39%
1년 성능:
-3.49%
1일 변동 폭
$6.45
$6.9141
1주일 범위
$5.89
$6.9999
52주 변동 폭
$5.00
$19.00
바이케리어스 서지컬 Stock (RBOT) Company Profile
명칭
Vicarious Surgical Inc
전화
(617) 868-1700
주소
78 FOURTH AVENUE, WALTHAM
RBOT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RBOT
Vicarious Surgical Inc
|
6.64 | 39.70M | 0 | -59.63M | -49.92M | -10.08 |
|
ABT
Abbott Laboratories
|
131.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.39 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.33 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.18 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.27 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
바이케리어스 서지컬 Stock (RBOT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-03-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | 개시 | Credit Suisse | Outperform |
| 2021-12-07 | 개시 | Cowen | Outperform |
| 2021-11-05 | 개시 | Canaccord Genuity | Buy |
| 2021-10-18 | 개시 | BTIG Research | Buy |
| 2021-10-07 | 개시 | Piper Sandler | Overweight |
모두보기
바이케리어스 서지컬 주식(RBOT)의 최신 뉴스
Breakout Traders Target Vicarious Surgical Inc. on Recovery SetupWeekly Trend Recap & Trade Opportunity Analysis - thegnnews.com
Vicarious Surgical Inc. Uptrend in Early Stages Indicators Say YesEarnings Recap Report & Weekly Market Pulse Updates - classian.co.kr
Will Vicarious Surgical Inc. Equity Warrant Bounce From 52 Week Low2025 Bull vs Bear & Weekly High Conviction Ideas - 선데이타임즈
RSI Reset May Fuel Rebound in Vicarious Surgical Inc.July 2025 Review & Long-Term Safe Investment Ideas - 선데이타임즈
Vicarious Surgical’s Earnings Call: Progress Amid Challenges - MSN
Will Vicarious Surgical Inc. benefit from rising consumer demandWeekly Market Outlook & Long-Term Growth Stock Strategies - thegnnews.com
Vicarious Surgical outlines new CEO transition and strategic shift to production system readiness amid $50M cash burn target - MSN
Moving Average Crossover Confirms Uptrend in Vicarious Surgical Inc.2025 Price Action Summary & Daily Profit Focused Stock Screening - 선데이타임즈
Vicarious Surgical Reports Improved Q2 Financials and Leadership Change - TipRanks
Vicarious Surgical appoints new CEO; co-founder Adam Sachs to remain as president - MSN
Published on: 2025-08-15 06:11:29 - thegnnews.com
Using data tools to time your Vicarious Surgical Inc. exit2025 Macro Impact & Short-Term High Return Strategies - Newser
Vicarious Surgical delays robot clinical timeline - Yahoo Finance
How hedge fund analytics apply to Vicarious Surgical Inc. Equity Warrant stockQuarterly Trade Report & Precise Buy Zone Tips - Newser
Best data tools to analyze Vicarious Surgical Inc. Equity Warrant stockJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - Newser
Vicarious Surgical Inc. stock volume spike explainedTrade Risk Summary & Community Trade Idea Sharing - Newser
Regression analysis insights on Vicarious Surgical Inc. performanceWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
What does recent volatility data suggest for Vicarious Surgical Inc.Analyst Upgrade & Smart Investment Allocation Insights - Newser
Using economic indicators to assess Vicarious Surgical Inc. potentialPortfolio Value Summary & Low Drawdown Investment Ideas - Newser
Trend analysis for Vicarious Surgical Inc. this weekBuy Signal & Growth Oriented Trade Recommendations - Newser
What MACD and RSI say about Vicarious Surgical Inc.July 2025 Summary & Expert Approved Trade Ideas - Newser
Vicarious Surgical delays robot timeline - medtechdive.com
RBOT Plunges 24.6%: Leadership Shift and Sector Turbulence Spark Investor Frenzy - AInvest
What institutional flow reveals about Vicarious Surgical Inc.2025 Stock Rankings & Real-Time Volume Triggers - Newser
Piper Sandler lowers Vicarious Surgical stock price target on delayed clinical use By Investing.com - Investing.com South Africa
Piper Sandler lowers Vicarious Surgical stock price target on delayed clinical use - Investing.com Nigeria
Tools to monitor Vicarious Surgical Inc. Equity Warrant recovery probabilityMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
Will Vicarious Surgical Inc. rebound enough to break evenJuly 2025 Movers & Daily Oversold Bounce Ideas - Newser
Vicarious Surgical Inc. (NYSE:RBOT) Q2 2025 Earnings Call Transcript - Insider Monkey
Earnings visualization tools for Vicarious Surgical Inc.2025 AllTime Highs & Reliable Intraday Trade Alerts - Newser
Live market analysis of Vicarious Surgical Inc.July 2025 Macro Moves & Low Risk Entry Point Guides - Newser
Tick level data insight on Vicarious Surgical Inc. volatilityMarket Sentiment Report & Low Risk Profit Maximizing Plans - Newser
Combining price and volume data for Vicarious Surgical Inc. Equity Warrant2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Is Vicarious Surgical Inc. Equity Warrant forming a bottoming baseRecession Risk & Fast Exit/Entry Strategy Plans - Newser
Vicarious Surgical Narrows Loss in Q2 - AOL.com
Can Vicarious Surgical Inc. Equity Warrant recover in the next quarterProfit Target & Fast Gaining Stock Strategy Reports - Newser
Vicarious Surgical Inc (RBOT) Q2 2025 Earnings Call Highlights: Strategic Delays and Cost Reductions By GuruFocus - Investing.com Canada
Published on: 2025-08-13 09:06:39 - beatles.ru
Published on: 2025-08-13 01:02:27 - Newser
Will Vicarious Surgical Inc. Equity Warrant outperform the marketEarnings Growth Report & Real-Time Volume Analysis - Newser
Will a bounce in Vicarious Surgical Inc. Equity Warrant offer an exitNew Guidance & Expert Approved Momentum Trade Ideas - Newser
Vicarious Surgical's Q2 2025: Unraveling Contradictions in Clinical Trials, System Readiness, and Supply Chain Stability - AInvest
Vicarious Surgical Narrows Loss in Q2 - The Motley Fool
Statistical indicators supporting Vicarious Surgical Inc.’s strength [Earnings Summary Report]Low Drawdown Investment Ideas - Newser
Price momentum metrics for Vicarious Surgical Inc. Equity Warrant explained [Market Risk Analysis] - Newser
Earnings call transcript: Vicarious Surgical’s Q2 2025 results show cost efficiency - Investing.com Nigeria
Transcript : Vicarious Surgical Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Surgical Robotics Pioneer Vicarious Cuts Losses 13% as New CEO Takes Helm - Stock Titan
Vicarious Surgical Reports Second Quarter 2025 Financial Results - Bluefield Daily Telegraph
바이케리어스 서지컬 (RBOT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.67%
자본화:
|
볼륨(24시간):